424.55
-0.64%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 697.56 697.20 586.11 0.05% 19.02%
EBITDA 87.57 83.81 73.53 4.49% 19.10%
Op. profit margin(%) 12.47 11.56 12.27 7.83% 1.60%
Net Profit 38.91 35.10 36.88 10.86% 5.51%
EPS 7.02 6.34 6.66 10.73% 5.41%
* Consolidated data
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 0.00 0.00 0.00 - -
EBITDA -0.27 -0.43 -2.38 37.40% 88.65%
Net Profit -0.93 -0.85 -2.38 -8.33% 61.07%
EPS -0.10 -0.09 -0.46 -11.11% 78.26%
* Consolidated data
26.02
1.48%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 225.14 152.52 168.73 47.61% 33.43%
EBITDA 9.99 4.38 13.16 128.01% -24.08%
Op. profit margin(%) 3.06 1.82 6.60 67.75% -53.69%
Net Profit 5.85 2.17 8.62 169.49% -32.15%
EPS 0.57 0.23 0.83 147.83% -31.33%
* Standalone data
logo
YES Bank Ltd.
17 Oct 2026
17.30
0.58%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 8649.54 8054.49 7388.75 7.39% 17.06%
EBITDA 7195.76 6580.06 5983.68 9.36% 20.26%
Op. profit margin(%) 19.46 21.17 17.73 -8.09% 9.77%
Net Profit 1084.08 1071.80 664.31 1.15% 63.19%
EPS 0.35 0.34 0.21 2.94% 66.67%
* Consolidated data
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 1.43 0.00 0.00 - 1428900.00%
EBITDA 0.01 -0.07 -0.04 107.29% 113.17%
Op. profit margin(%) 0.38 - -41000.00 - 100.00%
Net Profit 0.01 -0.07 -0.03 107.14% 117.15%
EPS 0.01 -0.21 -0.09 104.76% 111.11%
* Standalone data
Hemo Organic Ltd - 524590 - Board Meeting Outcome for The Meeting Held Today I.E., Saturday, …
BSE India
The Board of Directors ('the Board') at its meeting held on 17th October, 2026 which commenced at 04:00 p.m. and concluded at 06:30 p.m., has approved and taken on record inter alia: a) The Un-audited Standalone Financial Results of the Company for the quarter and half year ended 30th September, 2026 prepared in terms of Regulation 33 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, along with Limited Review Report thereon submitted by the statutory auditors. b) To transact other businesses as per agenda being circulated.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 1.43 0.00 0.00 - 1428900.00%
EBITDA 0.01 -0.07 -0.04 107.29% 113.17%
Op. profit margin(%) 0.38 - -41000.00 - 100.00%
Net Profit 0.01 -0.07 -0.03 107.14% 117.15%
EPS 0.01 -0.21 -0.09 104.76% 111.11%
* Standalone data
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 3394.48 3213.37 2998.87 5.64% 13.19%
EBITDA 2798.94 2626.16 2406.23 6.58% 16.32%
Op. profit margin(%) 18.19 16.98 16.84 7.15% 8.00%
Net Profit 411.97 331.51 294.52 24.27% 39.88%
EPS 0.58 0.47 0.42 23.40% 38.10%
* Standalone data
297.45
2.22%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 235.09 184.34 130.92 27.53% 79.57%
EBITDA 32.77 22.94 15.80 42.83% 107.42%
Op. profit margin(%) 13.02 12.23 11.27 6.39% 15.51%
Net Profit 19.69 13.31 8.08 47.88% 143.52%
EPS 3.08 2.06 1.25 49.51% 146.40%
* Standalone data
9.37
0.86%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 5.42 8.33 8.61 -34.90% -36.99%
EBITDA 1.68 1.81 1.88 -7.43% -10.69%
Op. profit margin(%) 24.06 17.25 17.78 39.48% 35.28%
Net Profit 0.10 0.19 0.21 -48.97% -52.01%
EPS 0.03 0.07 0.07 -57.14% -57.14%
* Standalone data
315.20
1.45%
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 175.90 165.63 147.91 6.20% 18.92%
EBITDA 31.81 29.37 27.26 8.33% 16.69%
Op. profit margin(%) 17.74 17.36 18.22 2.21% -2.62%
Net Profit 14.09 13.70 11.11 2.89% 26.87%
EPS 4.19 4.07 3.53 2.95% 18.70%
* Standalone data